This unknown stock signed an Exclusive Counter-Drone Technology License Agreement
Add in the Non-Lethal Low Energy Cartridge as a potential alternative to Police using handguns

And you have a potentially explosive company.
Click here to learn more

CRBU Insider Trading (Caribou Biosciences)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $250,027.05
Insider Selling (Last 12 Months): $0.00

Caribou Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Caribou Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Caribou Biosciences Share Price & Price History

Current Price: $22.79
Price Change: Price Decrease of -0.36 (-1.56%)
As of 10/27/2021 05:00 PM ET

This chart shows the closing price history over time for CRBU up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Fake meat? This company is cornering the plant-based market
This could become one of the greatest growth stories of our lifetimes

This tiny plant-based firm has explosive growth
Get the FREE investor deck

Caribou Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/20/2021Barbara G. McClungInsiderBuy9,219$2.69$24,799.11View SEC Filing Icon  
10/12/2021Steven KannerInsiderBuy114,860$1.92$220,531.20View SEC Filing Icon  
10/11/2021Ryan FischesserVPBuy1,746$2.69$4,696.74View SEC Filing Icon  
See Full Table
Insider Buying at Caribou Biosciences?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Caribou Biosciences and related companies.

SEC Filings (Institutional Ownership Changes) for Caribou Biosciences (NASDAQ:CRBU)

Caribou Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/22/2021Strs Ohio4,400$0.11M0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Caribou Biosciences logo
Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors. Caribou Biosciences Inc. is based in BERKELEY, Calif.
Read More on Caribou Biosciences

Today's Range

Now: $22.79
Low: $21.95
High: $23.47

50 Day Range

MA: $25.28
Low: $19.16
High: $30.29

52 Week Range

Now: $22.79
Low: $15.00
High: $32.65

Volume

216,092 shs

Average Volume

781,907 shs

Market Capitalization

$1.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Caribou Biosciences?

Caribou Biosciences' top insider shareholders include:
  1. Barbara G Mcclung (Insider)
  2. Ryan Fischesser (VP)
  3. Steven Kanner (Insider)

Who are the major institutional investors of Caribou Biosciences?

Caribou Biosciences' top institutional shareholders include:
  1. Strs Ohio — 0.01%

Which institutional investors are buying Caribou Biosciences stock?

During the last quarter, CRBU stock was acquired by institutional investors including:
  1. Strs Ohio
During the last year, these company insiders have bought Caribou Biosciences stock:
  1. Barbara G Mcclung (Insider)
  2. Ryan Fischesser (VP)
  3. Steven Kanner (Insider)
This unknown stock signed an Exclusive Counter-Drone Technology License Agreement
Add in the Non-Lethal Low Energy Cartridge as a potential alternative to Police using handguns

And you have a potentially explosive company.
Click here to learn more